[go: up one dir, main page]

NO981539D0 - Gelformuleringer inneholdende vekstfaktorer - Google Patents

Gelformuleringer inneholdende vekstfaktorer

Info

Publication number
NO981539D0
NO981539D0 NO981539A NO981539A NO981539D0 NO 981539 D0 NO981539 D0 NO 981539D0 NO 981539 A NO981539 A NO 981539A NO 981539 A NO981539 A NO 981539A NO 981539 D0 NO981539 D0 NO 981539D0
Authority
NO
Norway
Prior art keywords
gel formulations
growth factors
gel
formulations containing
containing growth
Prior art date
Application number
NO981539A
Other languages
English (en)
Other versions
NO981539L (no
Inventor
John Cini
Amy Finkenur
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of NO981539D0 publication Critical patent/NO981539D0/no
Publication of NO981539L publication Critical patent/NO981539L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Materials For Medical Uses (AREA)
NO981539A 1995-10-06 1998-04-03 Gelformuleringer inneholdende vekstfaktorer NO981539L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/539,898 US5705485A (en) 1987-09-18 1995-10-06 Gel formulations containing growth factors
PCT/US1996/015288 WO1997012601A2 (en) 1995-10-06 1996-09-24 Gel formulations containing growth factors

Publications (2)

Publication Number Publication Date
NO981539D0 true NO981539D0 (no) 1998-04-03
NO981539L NO981539L (no) 1998-06-02

Family

ID=24153118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981539A NO981539L (no) 1995-10-06 1998-04-03 Gelformuleringer inneholdende vekstfaktorer

Country Status (19)

Country Link
US (1) US5705485A (no)
EP (1) EP0859596B1 (no)
JP (1) JP4001382B2 (no)
KR (1) KR100444417B1 (no)
CN (1) CN1142791C (no)
AT (1) ATE209900T1 (no)
AU (1) AU706806B2 (no)
BR (1) BR9610790A (no)
CA (1) CA2234235C (no)
CZ (1) CZ294676B6 (no)
DE (1) DE69617723T2 (no)
DK (1) DK0859596T3 (no)
ES (1) ES2167611T3 (no)
HU (1) HU223880B1 (no)
NO (1) NO981539L (no)
PL (1) PL187174B1 (no)
PT (1) PT859596E (no)
WO (1) WO1997012601A2 (no)
ZA (1) ZA968398B (no)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6636098A (en) * 1998-03-07 1999-09-20 Dae Woong Pharmaceutical Co., Ltd. Topical composition containing human epidermal growth factor
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
CA2341410C (en) 1998-09-04 2007-11-20 Scios Inc. Hydrogel compositions for the controlled release administration of growth factors
US6057280A (en) 1998-11-19 2000-05-02 Huish Detergents, Inc. Compositions containing α-sulfofatty acid esters and methods of making and using the same
DE19925519A1 (de) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Wundauflage zur gesteuerten Abgabe von Wirkstoff an Wunden und Verfahren zu ihrer Herstellung
AU5624500A (en) * 1999-06-18 2001-01-09 Collaborative Group, Ltd., The Hyaluronic acid microspheres for sustained gene transfer
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
CN100379462C (zh) 1999-11-09 2008-04-09 电气化学工业株式会社 一种包含难溶于水的可溶性纤维素衍生物的组织包被性医疗材料及其制造方法
DE10048260A1 (de) * 2000-09-29 2002-04-11 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Aminoguanidin und/oder dessen Derivaten und Strukturanaloga zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
US6703039B2 (en) * 2000-12-06 2004-03-09 Bausch & Lomb Incorporated Reversible gelling system for ocular drug delivery
WO2002058718A2 (en) * 2001-01-26 2002-08-01 Genetix Pharmaceuticals, Inc. Use of compositions containing pdgf-bb for promoting angiogenesis
DE10140623A1 (de) * 2001-08-18 2003-03-06 Nawa Heilmittel Gmbh Pharmazeutisches Präparat zur Behandlung von Wunden
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US7037504B2 (en) * 2001-10-23 2006-05-02 Waratah Pharmaceuticals, Inc. Epidermal growth factor protein and gene, and methods of use therefor
US20080086792A1 (en) 2006-10-13 2008-04-17 Thomas Charles Kuracina Method and apparatus for diverting sweat, liquid, moisture or the like from an eye
DE60325827D1 (de) 2002-02-21 2009-03-05 Encelle Inc Vernetzte bioaktive hydrogel-matrizen
US20030220632A1 (en) * 2002-05-23 2003-11-27 Wolfgang Strasser Method of using gel sheets for laser treatment
ATE497778T1 (de) * 2002-09-16 2011-02-15 Agennix Inc Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
EP1654002B2 (en) * 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes
WO2005060550A2 (en) 2003-12-11 2005-07-07 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
CN100411615C (zh) * 2003-12-12 2008-08-20 上海第二医科大学附属瑞金医院 氨基胍对难愈创面的防治作用
WO2005077402A1 (en) * 2004-02-11 2005-08-25 Virchow Biotech Private Limited Honey based gel formulations
WO2006015302A1 (en) * 2004-07-29 2006-02-09 X-Sten, Corp. Spinal ligament modification devices
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
BRPI0613284A2 (pt) * 2005-06-17 2010-12-28 Genentech Inc métodos de aceleração de cicatrização de ferida
WO2007013100A1 (en) * 2005-07-26 2007-02-01 Virchow Biotech Private Limited Gel formulation comprising platelet derived growth factor
WO2007016684A2 (en) * 2005-07-29 2007-02-08 X-Sten, Corp. Tools for percutaneous spinal ligament decompression and device for supporting same
WO2007016686A2 (en) * 2005-07-29 2007-02-08 Vertos Medical, Inc. Percutaneous tissue excision devices and methods
FR2891149B1 (fr) * 2005-09-26 2007-11-30 Biodex Sarl Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes.
US9278161B2 (en) * 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
KR100687281B1 (ko) * 2005-11-30 2007-02-27 한국과학기술연구원 생리 활성 물질이 결합된 조직 재생용 주입형 온도 감응성플루로닉 유도체 하이드로겔 및 이의 제조 방법
KR100742313B1 (ko) * 2006-03-21 2007-07-24 퓨리메드 주식회사 신규한 혈소판 유래 성장 인자(ｐｄｇｆ) ｂ 폴리펩타이드및 이의 유전자
US7942830B2 (en) 2006-05-09 2011-05-17 Vertos Medical, Inc. Ipsilateral approach to minimally invasive ligament decompression procedure
KR100784134B1 (ko) * 2006-10-09 2007-12-12 주식회사 대웅 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물
JP5216596B2 (ja) * 2006-10-26 2013-06-19 千寿製薬株式会社 眼科用水性液剤
US8343536B2 (en) 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
US20080221383A1 (en) * 2007-02-12 2008-09-11 Vertos Medical, Inc. Tissue excision devices and methods
US20090118709A1 (en) * 2007-11-06 2009-05-07 Vertos Medical, Inc. A Delaware Corporation Tissue Excision Tool, Kits and Methods of Using the Same
JP5582711B2 (ja) * 2008-09-25 2014-09-03 株式会社エー・アイ・システムプロダクト ローション状の塗薬
USD610259S1 (en) 2008-10-23 2010-02-16 Vertos Medical, Inc. Tissue modification device
USD619253S1 (en) 2008-10-23 2010-07-06 Vertos Medical, Inc. Tissue modification device
USD611146S1 (en) 2008-10-23 2010-03-02 Vertos Medical, Inc. Tissue modification device
USD619252S1 (en) 2008-10-23 2010-07-06 Vertos Medical, Inc. Tissue modification device
USD621939S1 (en) 2008-10-23 2010-08-17 Vertos Medical, Inc. Tissue modification device
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
CN102548538B (zh) * 2009-09-22 2014-03-12 V生命科学技术有限公司 治疗糖尿病足溃疡的局部制剂
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
EP2729219A4 (en) * 2011-07-06 2015-04-01 Orf Líftaekni Hf METHOD OF USING NON-VEGETABLE GROWTH FACTOR STABILIZED FOR SKIN CARE
US9561247B2 (en) 2011-11-02 2017-02-07 Tif Management, Llc Methods and compositions for wound treatment
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9422497B2 (en) 2012-09-21 2016-08-23 Exxonmobil Research And Engineering Company Synthetic lubricant basestocks and methods of preparation thereof
EP2968462B1 (en) 2013-03-15 2020-12-23 The Jackson Laboratory Methods for promoting wound healing and hair growth
AU2014233494B2 (en) 2013-03-15 2018-10-04 Genentech, Inc. IL-22 polypeptides and IL-22 Fc fusion proteins and methods of use
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
MX2017004520A (es) * 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.
WO2017035280A1 (en) * 2015-08-24 2017-03-02 Nugene, Inc. Skin damage healing aids and dressings
CA3015400C (en) * 2016-02-23 2024-10-29 Matripharm International Inc. DUAL-RATE, HIGH-DRUGGED COMPOSITION
ES2870603T3 (es) 2016-09-07 2021-10-27 Vertos Medical Inc Instrumentos de resección de receso lateral percutánea
EP3624731A4 (en) * 2017-05-18 2021-02-24 The Board of Trustees of the Leland Stanford Junior University TARGETED IN-SITU THERAPEUTIC ADMINISTRATION OF SECRETED FACTORS FROM STEM CELLS FOR THE TREATMENT OF DAMAGED TISSUE
LT3743088T (lt) 2018-01-26 2022-12-27 F. Hoffmann-La Roche Ag Il-22 fc kompozicijos ir jų naudojimo būdai
AU2019212709A1 (en) 2018-01-26 2020-08-13 Genentech, Inc. IL-22 Fc fusion proteins and methods of use
EP3755364A1 (en) 2018-02-21 2020-12-30 F. Hoffmann-La Roche AG Dosing for treatment with il-22 fc fusion proteins
CN114601959A (zh) * 2020-11-23 2022-06-10 山东融元康医疗科技有限公司 一种医用皮肤护理敷料及其制备方法和应用
WO2023245144A1 (en) 2022-06-16 2023-12-21 Vertos Medical, Inc. Integrated instrument assembly

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190361B (it) * 1985-05-30 1988-02-16 Zambon Spa Composizione farmaceutica in crema per uso dermale ed oftalmico
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5457093A (en) * 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
WO1993000050A1 (en) * 1991-06-21 1993-01-07 Genetics Institute, Inc. Pharmaceutical formulations of osteogenic proteins
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
AU3062392A (en) * 1991-11-04 1993-06-07 Novo Nordisk A/S Pdgf gel formulation
JP3102655B2 (ja) * 1991-12-27 2000-10-23 住友製薬株式会社 超音波制御による薬物放出製剤

Also Published As

Publication number Publication date
CN1211191A (zh) 1999-03-17
PT859596E (pt) 2002-05-31
CZ294676B6 (cs) 2005-02-16
CA2234235C (en) 2002-05-14
DE69617723D1 (de) 2002-01-17
WO1997012601A2 (en) 1997-04-10
DE69617723T2 (de) 2002-05-08
DK0859596T3 (da) 2002-03-04
HUP9803002A2 (hu) 1999-04-28
PL326064A1 (en) 1998-08-17
KR19990064041A (ko) 1999-07-26
PL187174B1 (pl) 2004-05-31
CZ102498A3 (cs) 1999-08-11
BR9610790A (pt) 1999-07-13
NO981539L (no) 1998-06-02
CA2234235A1 (en) 1997-04-10
US5705485A (en) 1998-01-06
ATE209900T1 (de) 2001-12-15
WO1997012601A3 (en) 1997-05-01
JPH11512740A (ja) 1999-11-02
AU706806B2 (en) 1999-06-24
KR100444417B1 (ko) 2004-11-03
EP0859596B1 (en) 2001-12-05
ES2167611T3 (es) 2002-05-16
EP0859596A2 (en) 1998-08-26
JP4001382B2 (ja) 2007-10-31
AU7370796A (en) 1997-04-28
CN1142791C (zh) 2004-03-24
HUP9803002A3 (en) 2001-08-28
ZA968398B (en) 1998-04-06
HU223880B1 (hu) 2005-02-28

Similar Documents

Publication Publication Date Title
ATE209900T1 (de) Wachsumsfaktoren enthaltende gelformulierungen
EP0383363A3 (en) Use of wound healing agents
EP1563844A3 (en) Wound healing formulations containing human plasma fibronectin
DE68926051D1 (de) Polypeptid-polymer-konjugate mit wundheilender wirkung
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
FI886019A7 (fi) Laastari vaikuttavien aineiden valvotusti jakamiseksi iholle
PT941108E (pt) Cicatrizacao de feridas e tratamento da fibrose
ES2065696T3 (es) Composicion farmaceutica.
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
UA23369A (uk) Антисептичний перев`язний матеріал